Search Results - "Prinz, J."

DNA origami based Au-Ag-core-shell nanoparticle dimers with single-molecule SERS sensitivity by Prinz, J, Heck, C, Ellerik, L, Merk, V, Bald, I

“…DNA origami nanostructures are a versatile tool to arrange metal nanostructures and other chemical entities with nanometer precision. In this way gold…”
Get more information

Prevention Science and Health Equity: A Comprehensive Framework for Preventing Health Inequities and Disparities Associated with Race, Ethnicity, and Social Class by Biglan, Anthony, Prinz, Ronald J., Fishbein, Diana

“…The ultimate goal of our public health system is to reduce the incidence of disability and premature death. Evidence suggests that, by this standard, the USA…”
Get full text

The Aesthetic Self. The Importance of Aesthetic Taste in Music and Art for Our Perceived Identity by Fingerhut, Joerg, Gomez-Lavin, Javier, Winklmayr, Claudia, Prinz, Jesse J

“…To what extent do aesthetic taste and our interest in the arts constitute who we are? In this paper, we present a series of empirical findings that suggest an…”
Get full text

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE) by Blauvelt, A., Prinz, J.C., Gottlieb, A.B., Kingo, K., Sofen, H., Ruer-Mulard, M., Singh, V., Pathan, R., Papavassilis, C., Cooper, S.

“…Summary Background Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, demonstrated efficacy and safety in moderate‐to‐severe plaque psoriasis…”
Get full text

Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis by Alsenaid, A., Prinz, J.C.

Get full text

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up by Langley, R.G., Lebwohl, M., Krueger, G.G., Szapary, P.O., Wasfi, Y., Chan, D., Hsu, M.C., You, Y., Poulin, Y., Korman, N., Prinz, J.C., Reich, K.

“…Summary Background Evaluation of the dosing flexibility and long‐term efficacy of biological agents is limited. Objectives To evaluate the long‐term efficacy…”
Get full text

Population-Based Prevention of Child Maltreatment: The U.S. Triple P System Population Trial by Prinz, Ronald J., Sanders, Matthew R., Shapiro, Cheri J., Whitaker, Daniel J., Lutzker, John R.

“…The prevention of child maltreatment necessitates a public health approach. In the U.S. Triple P System Population Trial, 18 counties were randomly assigned to…”
Get full text

Influence of Covid‐19 vaccination on immune‐mediated skin diseases by Alelq, N. A., Kubieniec, M. E., French, L. E, Prinz, J. C.

Get full text

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction by Papp, K.A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C.E.M., Nakanishi, A.M., Zitnik, R., Van De Kerkhof, P.C.M.

“…Summary Background  In previous studies, etanercept significantly improved plaque psoriasis and was well tolerated. Objectives  To examine further the efficacy…”
Get full text

Potential roles of parental self-efficacy in parent and child adjustment: A review by Jones, Tracy L., Prinz, Ronald J.

“…This review examines the potential roles of parental self-efficacy (PSE) in parent and child adjustment and the role of parental cognitions in understanding…”
Get full text

The genetic basis for most patients with pustular skin disease remains elusive by Mössner, R., Wilsmann‐Theis, D., Oji, V., Gkogkolou, P., Löhr, S., Schulz, P., Körber, A., Prinz, J.C., Renner, R., Schäkel, K., Vogelsang, L., Peters, K.‐P., Philipp, S., Reich, K., Ständer, H., Jacobi, A., Weyergraf, A., Kingo, K., Kõks, S., Gerdes, S., Steinz, K., Schill, T., Griewank, K. G., Müller, M., Frey, S., Ebertsch, L., Uebe, S., Sticherling, M., Sticht, H., Hüffmeier, U.

“…Summary Background Rare variants in the genes IL36RN, CARD14 and AP1S3 have been identified to cause or contribute to pustular skin diseases, primarily…”
Get full text

Lesional activation of Tc17 cells in Behçet disease and psoriasis supports HLA class I‐mediated autoimmune responses by Vural, S., Kerl, K., Ertop Doğan, P., Vollmer, S., Puchta, U., He, M., Arakawa, Y., Heper, A.O., Karal‐Öktem, A., Hartmann, D., Boyvat, A., Prinz, J.C., Arakawa, A.

“…Summary Background Behçet disease (BD) presents with lymphocytic and neutrophilic vasculitis of unknown aetiology. HLA‐B*51, the endoplasmic reticulum…”
Get full text

Genetics and Crime: Integrating New Genomic Discoveries Into Psychological Research About Antisocial Behavior by Wertz, J., Caspi, A., Belsky, D. W., Beckley, A. L., Arseneault, L., Barnes, J. C., Corcoran, D. L., Hogan, S., Houts, R. M., Morgan, N., Odgers, C. L., Prinz, J. A., Sugden, K., Williams, B. S., Poulton, R., Moffitt, T. E.

“…Drawing on psychological and sociological theories of crime causation, we tested the hypothesis that genetic risk for low educational attainment (assessed via…”
Get full text

Adopting a population-level approach to parenting and family support interventions by Prinz, Ronald J., Sanders, Matthew R.

“…Evidence-based treatments and preventive interventions in the child and family area have not met with widespread adoption by practitioners. Despite the high…”
Get full text

Treatment of psoriasis with etanercept: the typical patient profile by Prinz, J.C., Puig, L., Girolomoni, G.

“…The chronic nature of psoriasis means that patients often require lifetime treatment. Over this time, treatment frequently has to be adapted to meet variable…”
Get full text

Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper by Girolomoni, G., Griffiths, C. E. M., Krueger, J., Nestle, F. O., Nicolas, J-F., Prinz, J. C., Puig, L., Ståhle, M., van de Kerkhof, P. C. M., Allez, M., Emery, P., Paul, C.

“…Abstract Psoriasis is an immune-mediated inflammatory disease (IMID) which may have a major impact on a patient's life, especially when the disease is moderate…”
Get full text

Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus by Torres, T, Brembilla, N C, Langley, R G, Warren, R B, Thaçi, D, Kolios, A G A, Prinz, J C, Londono-Garcia, A, Nast, A, Santin, M, Goletti, D, Abreu, M, Spuls, P, Boehncke, W H, Puig, L

“…Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a significant global health problem. In immunocompetent individuals, the microorganism can remain…”
Get full text

A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus by Strohal, R., Prinz, J. C., Girolomoni, G., Nast, A.

“…Background Each individual psoriasis patient has different expectations and goals for biological treatment, which may differ from those of the clinician. As…”
Get full text

Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis by Molin, S., Vollmer, S., Weiss, E.H., Ruzicka, T., Prinz, J.C.

“…Summary Background  The pathogenesis of chronic hand eczema (CHE) is multifactorial and involves both endogenous predisposition and environmental triggers…”
Get full text

The therapeutic potential of TNF‐α antagonists in toxic epidermal necrosis: insights from two cases and adverse event reports by Vural, S., Arakawa, A., Arakawa, Y., Prinz, J.C.

Get full text